Med Opportunity Partners Team

Med Opportunity Partners Team Summary

Med Opportunity Partners’ team includes 1 investment professional, and 1 operations personnel. The average tenure for the Firm’s senior team is 19 years.

Sign-up to view Med Opportunity Partners’ full profile and discover more small private equity firm investors just like it.

Team Summary

  • Investment 1
  • Operations 1

Med Opportunity Partners

Med Opportunity Partners LLC

Two Greenwich Office Park, Suite 300,
Greenwich, Connecticut 06831
United States
(203) 542-2858
www.medopportunity.com
breckenridge@medopportunity.com

All (2) Senior (2) Midlevel (-) Junior (-)
Name Title Email Phone Office
Vicente Trelles Co-Founder & Operating Partner confidential@email.com CONFIDENTIAL Greenwich

Mr. Trelles co-founded Med Opportunity Partners, LLC. From April 2011 to May 2013, Mr. Trelles was Executive Vice President, Worldwide Operations, Shared Services and R&D at Orthofix International, N.V. Orthofix is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. From 2001 to March 2006 he was Executive Vice President and COO of Inamed Corporation. Mr. Trelles was a senior member of INAMED’s management team that created over $2.8 billion of shareholder value in four years. During that period Inamed’s sales increased from $240 million to $430 million and earnings doubled. As Executive Vice President and Chief Operations Officer, Mr. Trelles was responsible for managing INAMED’s global operations including product development, regulatory compliance, and key strategic business partnerships. He currently serves as a director of the board of Revance Therapeutics Inc., a pre-IPO biotechnology company focused on targeted therapeutics and delivery systems, Vibrynt Corp. a medical device start up company focused on obesity and Reliable Biopharmaceutical Corporation. Mr. Trelles has spent over 24 years within the medical device and pharmaceutical industries managing global operations at INAMED, Allergan and Baxter Healthcare. From 1999-2001, he was the Chief Operating Officer of McGhan Medical (a wholly owned subsidiary of INAMED) From 1990-1999, Mr. Trelles was a senior operating executive at Allergan, Inc. including, VP Worldwide Surgical Operations, Vice President Europe Operations, Vice President of Manufacturing for their Contact Lens Business and General Manager of the Contact Lens Division in Puerto Rico. From 1981-1990, Mr. Trelles held management positions of increasing responsibilities at Baxter Health Care Corporation and American Hospital Supply including General Manager of its V. Mueller Division in Puerto Rico. Mr. Trelles received a BS in Industrial Engineering from the University of Puerto Rico.

Function: Operations

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.